Platelet Rich Plasma for Musculoskeletal Conditions
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
Sponsor: University of Utah
You may qualify if…
- ✓ 18+ years old
- ✓ Musculoskeletal pathology that may benefit from a PRP injection
- ✓ Failed other conservative treatments
You may not qualify if…
- ✕ No active malignancy
- ✕ No active infection in the area of injection
- ✕ No platelet disorder
- ✕ No active systemic infections
- ✕ No patients currently undergoing dialysis
Where it's recruiting
Salt Lake City
Source: ClinicalTrials.gov · NCT07231471 · last updated 2026-05-06